FDA Approved: RIVIVE — Original Application (Harm Reduction Therapeutics, Inc.)

View source ↗

Summary

FDA approved the original application for RIVIVE (naloxone hydrochloride) by Harm Reduction Therapeutics, Inc. for emergency reversal of opioid overdose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• RIVIVE (Naloxone hydrochloride)

Snippet

ORIG AP for RIVIVE (NALOXONE HYDROCHLORIDE)